Why is BioAge Labs, Inc. ?
1
Positive results in Mar 26
- NET PROFIT(HY) Higher at USD -47.87 MM
- RAW MATERIAL COST(Y) Fallen by -0.29% (YoY)
- NET SALES(Q) At USD 2.77 MM has Grown at 23.27%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 338.94%, its profits have fallen by -13%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -4.84% over the previous quarter and currently hold 20.37% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Market Beating Performance
- The stock has generated a return of 338.94% in the last 1 year, much higher than market (S&P 500) returns of 26.39%
How much should you hold?
- Overall Portfolio exposure to BioAge Labs, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
115.40%
EBIT Growth (5y)
-168.49%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.24%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.63
EV to EBIT
-4.73
EV to EBITDA
-4.74
EV to Capital Employed
-75.45
EV to Sales
48.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-29.55%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Movement
15What is working for the Company
NET PROFIT(HY)
Higher at USD -47.87 MM
RAW MATERIAL COST(Y)
Fallen by -0.29% (YoY
NET SALES(Q)
At USD 2.77 MM has Grown at 23.27%
OPERATING PROFIT MARGIN(Q)
Highest at -913.13 %
-6What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -88.31 MM
NET PROFIT(HY)
At USD -47.87 MM has Grown at -38.46%
Here's what is working for BioAge Labs, Inc.
Net Profit
Higher at USD -47.87 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
At USD 2.77 MM has Grown at 23.27%
over average net sales of the previous four periods of USD 2.25 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -913.13 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -0.29% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for BioAge Labs, Inc.
Net Profit
At USD -47.87 MM has Grown at -38.46%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -88.31 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)






